The Irish News | Latest cash injection sees medical tech firm Neurovalens target US growth
A BELFAST technology firm developing a number of specialised medical devices has received its second major cash injection in a month.
Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.
Belfast Newsletter | Health tech company creates 22 new jobs
Belfast-based health tech company Neurovalens is set to create 22 new jobs with the development of a ground-breaking medical device.
Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings.